VAR - Varian Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD
110.82
+1.84 (+1.69%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close 108.98
Open 109.93
Bid 100.00 x 800
Ask 111.34 x 800
Day's Range 109.93 - 112.26
52 Week Range 101.42 - 142.50
Volume 409,101
Avg. Volume 719,862
Market Cap 10.091B
Beta (3Y Monthly) 0.93
PE Ratio (TTM) 30.16
EPS (TTM) N/A
Earnings Date N/A
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date 1998-12-02
1y Target Est N/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • PR Newswire

    Varian Highlights Interventional Oncology Solutions at CIO Symposium

    PALO ALTO, Calif. , Oct. 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) will showcase the company's interventional oncology solutions at the Symposium on Clinical Interventional Oncology, October 11-13, 2019 ...

  • PR Newswire

    Varian U.S. Tariff Exclusion Request Granted for Radiotherapy System Components

    PALO ALTO, Calif. , Sept. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the United States Trade Representative (USTR) has granted exclusion of components sourced from China for linear accelerators ...

  • PR Newswire

    Varian Names Chief Medical Officer for Interventional Oncology

    Francis R. Facchini, M.D., FSIR, fills new role for interventional oncology globally PALO ALTO, Calif. , Sept.16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) has named Francis R. Facchini , M.D., FSIR, as ...

  • PR Newswire

    Varian Ranked Highest in Survey of US Radiation Oncology Professionals

    Company Ranked Highest in Eight Key Performance Areas and Net Promotor Score PALO ALTO, Calif. , Sept. 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) has been recognized again as a leader in the annual IMV ...

  • PR Newswire

    Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System

    PALO ALTO, Calif. , Sept. 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360° system is the ...

  • Varian Unveils Innovative New Solution for Adaptive Therapy
    PR Newswire

    Varian Unveils Innovative New Solution for Adaptive Therapy

    PALO ALTO, Calif., Sept. 15, 2019 /PRNewswire/ -- Strengthening its leadership in delivering innovative new solutions to transform cancer care globally, Varian (VAR) today announced Ethos™ therapy, an Adaptive Intelligence™ solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy.

  • PR Newswire

    Varian and Oncora Partner to Accelerate Precision Medicine in Radiation Oncology

    PALO ALTO, Calif. and PHILADELPHIA , Sept. 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it is investing in Oncora Medical and partnering to accelerate the development of software tools to ...

  • PR Newswire

    Varian Announces Fourth Quarter Fiscal Year 2019 Earnings Release Date

    PALO ALTO, Calif. , Sept. 12, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its fourth quarter fiscal year 2019 earnings release date. The Company will report results for the fourth quarter of ...

  • PR Newswire

    Varian Expects to Benefit from Linear Accelerator Tariff Exclusion in China

    PALO ALTO, Calif. and BEIJING, Sept. 11, 2019 /PRNewswire/ -- Varian (VAR) has received notice from the Customs Tariff Commission of the State Council of China that medical linear accelerators are excluded from the additional tariffs China imposed on US products that began on August 23, 2018. "We are grateful for the China government's determination to fight cancer and its recognition of the positive impact of radiotherapy treatments," said Dow Wilson, president and chief executive officer, Varian. "Varian envisions a world without fear of cancer, and we are committed to empowering our users to achieve new victories against cancer with our cancer care solutions.

  • PR Newswire

    Varian-equipped New York Proton Therapy Center Treats First Patients

    PALO ALTO, Calif. , Sept. 10, 2019 /PRNewswire/ -- The New York Proton Center (NYPC) has treated its first proton therapy cancer patients. Equipped with the Varian ProBeam ® proton therapy system, NYPC ...

  • PR Newswire

    Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at Sylvester Comprehensive Cancer Center

    PALO ALTO, Calif. , Aug. 28, 2019 /PRNewswire/ -- Varian (NYSE: VAR) has completed the installation of the cyclotron for its ProBeam ®  Compact single-room proton therapy system at Sylvester Comprehensive ...

  • PR Newswire

    Dr. Phil Febbo Named to Varian Board of Directors

    PALO ALTO, Calif., Aug. 21, 2019 /PRNewswire/ -- Varian (VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, 2019. "We are proud to have Phil Febbo join the Varian Board," said R. Andrew Eckert, chairman of Varian's Board of Directors. "Phil has a strong background in both clinical and research work, as well as company strategy.

  • PR Newswire

    Varian Completes Purchase of Embolic Bead Asset

    PALO ALTO, Calif. , Aug. 21, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and ...

  • PR Newswire

    Varian to Hold Investor Day in New York City

    PALO ALTO, Calif., Aug. 19, 2019 /PRNewswire/ -- Varian (VAR) today announced that its executive management team will be hosting an Investor Day on Friday, November 15, 2019 at The Plaza Hotel, Fifth Avenue at Central Park South, New York, NY 10019, from 8:00am to 1:00pm ET. Varian will outline its growth initiatives in radiation oncology, interventional oncology, and more broadly across cancer care driven by its 'Intelligent Cancer Care' approach, the next wave of progress in oncology that harnesses advanced technologies like artificial intelligence, machine learning, and data analytics to ensure coordination and connectivity at every point of care.  'Intelligent Cancer Care' puts the patient and provider at the center of our thinking to help realize our vision of a world without fear of cancer.

  • PR Newswire

    Varian to Host Investor Meeting at ASTRO in Chicago

    PALO ALTO, Calif., Aug. 8, 2019 /PRNewswire/ -- Varian (VAR) today announced that its executive staff will be meeting with analysts and investors at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago on Monday, September 16, 2019 at 2:00 p.m. Central Time. To attend Varian's ASTRO investor meeting, please RSVP to Katie Glenn at katie.glenn@varian.com by August 23, 2019. For automatic e-mail alerts regarding Varian news and events, investors can subscribe on the company website: http://investors.varian.com/emailalerts.

  • PR Newswire

    Varian Announces Immaterial Impact of Newly Proposed Tariffs

    PALO ALTO, Calif., Aug. 5, 2019 /PRNewswire/ -- Varian (VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company. Last Thursday, the U.S. announced plans to impose a 10 percent tax on $300 billion in Chinese imports beginning September 1, 2019.  Varian estimates these newly proposed tariffs should have an immaterial financial impact. At Varian, we envision a world without fear of cancer.  For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year.  With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care.  Our 9,200 employees across 70 countries keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care.  Because, for cancer patients everywhere, their fight is our fight.  For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

  • PR Newswire

    Three Radiotherapy Centers in Serbia Standardize on Varian Solution for Cancer Treatment Planning

    PALO ALTO, Calif. , July 29, 2019 /PRNewswire/ -- Following a public competitive review process, Varian (NYSE: VAR) was selected to supply its Eclipse ™ treatment planning software and ARIA ® oncology ...

  • PR Newswire

    Karolinska University Hospital Solna Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System

    PALO ALTO, Calif. and STOCKHOLM, July 25, 2019 /PRNewswire/ -- Varian (VAR) announced that the Karolinska University Hospital Solna in Sweden is the first hospital in Scandinavia to deliver High Dose Rate (HDR) brachytherapy treatments using the new Bravos™ afterloader system. Bravos is an advanced integrated system designed to improve the patient and clinic experience by simplifying brachytherapy treatments and provide greater workflow efficiency. HDR brachytherapy involves delivering radiotherapy by temporarily placing a small radioactive source directly into the tumor or other targeted area.

  • PR Newswire

    Varian Reports Results for Third Quarter of Fiscal Year 2019

    PALO ALTO, Calif. , July 24, 2019 /PRNewswire/ -- Third Quarter 2019 Summary Oncology Systems gross orders grew 2% in dollars, or 4% in constant currency; Trailing twelve months gross orders grew 11% in ...

  • PR Newswire

    Varian to Showcase Cancer Care Systems and Software at AAPM 2019

    PALO ALTO, Calif. , July 11, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be showcasing systems and software from its cancer care portfolio, including the IDENTIFY ™ Guidance System, ...

  • PR Newswire

    Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at King Chulalongkorn Memorial Hospital, Bangkok, Thailand

    Her Royal Highness Princess Maha Chakri Sirindhorn Presided Over Rigging Ceremony PALO ALTO, Calif. , July 9, 2019 /PRNewswire/ -- Varian (NYSE: VAR) celebrated the installation of the cyclotron for its ...

  • PR Newswire

    Varian Provides TrueBeam System for IAEA Dosimetry Laboratory in Austria

    PALO ALTO, Calif. , July 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) is working in partnership with the International Atomic Energy Agency (IAEA) to improve cancer treatment by helping hospitals around ...

  • PR Newswire

    Varian to Expand Interventional Oncology Portfolio with Purchase of Embolic Bead Asset

    PALO ALTO, Calif., July 2, 2019 /PRNewswire/ -- Varian (VAR) today announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. When completed, this acquisition, in combination with the recent acquisitions of Endocare and Alicon, will expand Varian's portfolio of multidisciplinary integrated cancer care solutions. Varian's planned acquisition of the Boston Scientific portfolio of drug-loadable microsphere (Oncozene/Embozene Tandem) and bland embolic (Embozene) bead products will enable Varian to extend its new interventional oncology platform, and the Company will benefit from the products' regulatory clearances in more than 35 countries worldwide.

  • PR Newswire

    Varian Announces Third Quarter Fiscal Year 2019 Earnings Release Date

    PALO ALTO, Calif. , June 26, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its third quarter fiscal year 2019 earnings release date. The Company will report results for the third quarter of fiscal ...

  • PR Newswire

    Varian to Provide Mobile Technology to Cancer Patients Across Tennessee

    Collaboration with Tennessee Oncology Aims to Improve Access to Care Across Rural Patient Populations PALO ALTO, Calif. , June 26, 2019 /PRNewswire/ -- Providing cancer patients an opportunity for increased ...